Navigation Links
Cephalon to Hold Public Memorial Service to Celebrate the Life of Company Founder, Frank Baldino, Jr., Ph.D.
Date:1/24/2011

FRAZER, Pa., Jan. 24, 2011 /PRNewswire/ -- Cephalon, Inc., (Nasdaq: CEPH) will hold a public memorial service to celebrate the life of the company's founder and late Chairman and CEO on February 1, 2011, at 6:00 p.m. at The Franklin Institute, 222 North 20th Street, Philadelphia, Pennsylvania.

Dr. Baldino founded Cephalon in 1987 and led the company from a privately held startup to one of the top ten biotechnology companies in the world. He was a recognized pioneer in the biotechnology industry; but, his most enduring legacy will be his accomplishments as a civic leader, a mentor, a philanthropist, and most notably, a husband and father.

Dr. Baldino died on December 16, 2010, from complications associated with leukemia. He was 57 years old.

Visit http://www.cephalon.com/frankbaldinojr/ to view Dr. Baldino's obituary, donate to a cause in his honor, view additional details about the memorial service, and pay tribute to him on an online memorial.  

About Cephalon, Inc.Cephalon is a global biopharmaceutical company dedicated to discovering, developing and bringing to market medications to improve the quality of life of individuals around the world. Since its inception in 1987, Cephalon has brought first-in-class and best-in-class medicines to patients in several therapeutic areas. Cephalon has the distinction of being one of the world's fastest-growing biopharmaceutical companies, now among the Fortune 1000 and a member of the S&P 500 Index, employing approximately 4,000 people worldwide. The company sells numerous branded and generic products around the world. In total, Cephalon sells more than 150 products in nearly 100 countries. More information on Cephalon and its products is available at http://www.cephalon.com/Media contacts:Fritz BittenbenderVice President, Public AffairsT: 610-883-5855Fbittenb@cephalon.comNatalie de VaneSr.  Director, Corporate Communications & Public AffairsT: 610-727-6536C: 484-319-3722ndevane@cephalon.com
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Cephalon Mourns the Passing of Founder, Chairman and CEO, Frank Baldino Jr., Ph.D.
2. Cephalon Announces Chairman and CEO to Remain on Medical Leave of Absence Indefinitely
3. Cephalon Reports Record Earnings and Raises 2010 Guidance
4. Drug Sales in the Leukemia Market Will Be Driven By Therapies From Novartis, Bristol-Myers Squibb, Biogen Idec, Roche and Cephalon
5. Cephalon Announces Chairman and CEO to Take Medical Leave of Absence
6. Cephalon Completes Acquisition of Arana Therapeutics
7. Cephalon Appoints Craig C. Phillips as Vice President and General Manager of Oncology Business Unit
8. Cephalon Quarterly Conference Call Invitation
9. Cephalon Prices 5 Million Shares of Common Stock and $435 Million in 2.50% Convertible Senior Subordinated Notes in Public Offerings
10. Cephalon Announces Proposed Public Offering of Common Stock and Convertible Senior Subordinated Notes
11. Cephalons New Product Launches Pace Record 2008 Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... From wearable devices that can ... sports. On Thursday, December 15th a panel of entrepreneurs, innovators and a Philadelphia ... at a Smart Talk session. Smart Talk will run from 8:30 – 10:30 ...
(Date:12/8/2016)... , ... December 08, 2016 , ... ... to control cells — optogenetics — is key to exciting advances in the ... art, spatially patterned light projected via free-space optics stimulates small, transparent organisms and ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc announced today ... demand KbioBox developed a sophisticated “3 click” gene dditing off target analysis program ... new website, https://www.kbiobox.com/ and powered by the company’s proprietary BioEngine. ...
(Date:12/8/2016)... 8, 2016 Soligenix, Inc. (OTCQB: SNGX) (Soligenix ... developing and commercializing products to treat rare diseases where ... it will be hosting an Investor Webcast Event Friday, ... origins of innate defense regulators (IDRs) as a new ... mucositis and the recently announced and published Phase 2 ...
Breaking Biology Technology:
(Date:11/15/2016)... , Nov 15, 2016 Research and ... Global Forecast to 2021" report to their offering. ... ... USD 16.18 Billion by 2021 from USD 6.21 Billion in 2016, ... Growth of the bioinformatics market is driven by the ...
(Date:6/22/2016)... 22, 2016  The American College of Medical Genetics and ... Magazine as one of the fastest-growing trade shows during ... the Bellagio in Las Vegas . ... of growth in each of the following categories: net square ... number of attendees. The 2015 ACMG Annual Meeting was ranked ...
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
Breaking Biology News(10 mins):